130 related articles for article (PubMed ID: 37309264)
1. Efficacy and tolerance of a novel topical TRPV-1 channel antagonist in dogs with allergic pododermatitis.
Serra Fabregat X; de Pablo MÁ; Hernán-Pérez C; Diéguez E; Valero Coppin O; Genové Corominas E
Vet Dermatol; 2023 Dec; 34(6):514-522. PubMed ID: 37309264
[TBL] [Abstract][Full Text] [Related]
2. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
Tamamoto-Mochizuki C; Murphy KM; Olivry T
Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
[TBL] [Abstract][Full Text] [Related]
3. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Cosgrove SB; Cleaver DM; King VL; Gilmer AR; Daniels AE; Wren JA; Stegemann MR
Vet Dermatol; 2015 Jun; 26(3):171-9, e35. PubMed ID: 25688708
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Martin DD; Walsh KF; Harfst JA; Follis SL; King VL; Boucher JF; Stegemann MR
Vet Dermatol; 2013 Oct; 24(5):479-e114. PubMed ID: 23829933
[TBL] [Abstract][Full Text] [Related]
6. Use of antipruritic and rehydrating foams on localized lesions of atopic dermatitis in dogs: a small-scale pilot and comparative double-blinded study.
Bensignor EJ; Fabriès LJ
Vet Dermatol; 2018 Oct; 29(5):446-e150. PubMed ID: 30079617
[TBL] [Abstract][Full Text] [Related]
7. Non-controlled, open-label clinical trial to assess the effectiveness of a dietetic food on pruritus and dermatologic scoring in atopic dogs.
Witzel-Rollins A; Murphy M; Becvarova I; Werre SR; Cadiergues MC; Meyer H
BMC Vet Res; 2019 Jun; 15(1):220. PubMed ID: 31253166
[TBL] [Abstract][Full Text] [Related]
8. Hair cortisol concentration, disease severity and quality of life in dogs with atopic dermatitis during lokivetmab therapy.
Stuart Marques V; Calesso JR; de Carvalho OV; da Costa-Val Bicalho AP
Vet Dermatol; 2023 Aug; 34(4):339-347. PubMed ID: 37165693
[TBL] [Abstract][Full Text] [Related]
9. A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client-owned dogs with allergic dermatitis.
Van Brussel L; Moyaert H; Escalada M; Mahabir SP; Stegemann MR
Vet Dermatol; 2021 Oct; 32(5):477-e131. PubMed ID: 34180084
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of low-level laser therapy on localized canine atopic dermatitis severity score and localized pruritic visual analog score in pedal pruritus due to canine atopic dermatitis.
Stich AN; Rosenkrantz WS; Griffin CE
Vet Dermatol; 2014 Oct; 25(5):464-e74. PubMed ID: 24909192
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study.
Noli C; Della Valle MF; Miolo A; Medori C; Schievano C;
Vet Dermatol; 2015 Dec; 26(6):432-40, e101. PubMed ID: 26283633
[TBL] [Abstract][Full Text] [Related]
12. Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.
Dip R; Carmichael J; Letellier I; Strehlau G; Roberts E; Bensignor E; Rosenkrantz W
BMC Vet Res; 2013 Sep; 9():173. PubMed ID: 24004561
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of AHR-13268, an antiallergenic compound, in the management of pruritus caused by atopic disease in dogs.
DeBoer DJ; Moriello KA; Pollet RA
Am J Vet Res; 1992 Apr; 53(4):532-6. PubMed ID: 1350185
[TBL] [Abstract][Full Text] [Related]
14. Development of a core outcome set for therapeutic clinical trials enrolling dogs with atopic dermatitis (COSCAD'18).
Olivry T; Bensignor E; Favrot C; Griffin CE; Hill PB; Mueller RS; Plant JD; Williams HC;
BMC Vet Res; 2018 Aug; 14(1):238. PubMed ID: 30115047
[TBL] [Abstract][Full Text] [Related]
15. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA.
Souza CP; Rosychuk RAW; Contreras ET; Schissler JR; Simpson AC
Vet Dermatol; 2018 Dec; 29(6):489-e164. PubMed ID: 30141223
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
18. Correlation between clinical efficacy on pruritus and serum interleukin-31 levels in dogs with atopic dermatitis treated with lokivetmab.
Calesso JR; Marques VS; de Carvalho OV; Costa-Val AP
Pol J Vet Sci; 2023 Jun; 26(2):231-238. PubMed ID: 37389418
[TBL] [Abstract][Full Text] [Related]
19. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
20. Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial.
Ahlstrom LA; Mason KV; Mills PC
J Vet Pharmacol Ther; 2010 Dec; 33(6):573-82. PubMed ID: 21062310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
